Technology
Health
Medical

Apollo Endosurgery

$3.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.27%) Today
-$0.04 (-1.07%) After Hours

Why Robinhood?

You can buy or sell APEN and other stocks, options, ETFs, and crypto commission-free!

About

Apollo Endosurgery, Inc. Common Stock, also called Apollo Endosurgery, is a medical technology company, which engages in the design, development, and commercialization of medical devices. Read More It offers medical devices for bariatric and gastrointestinal procedures under the ORBERA and OverStitch brands. The company was founded by Christopher J. Gostout in 2006 and is headquartered in Austin, TX.

Employees
215
Headquarters
Austin, Texas
Founded
2006
Market Cap
81.99M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
48.62K
High Today
$3.83
Low Today
$3.61
Open Price
$3.73
Volume
2.60K
52 Week High
$9.65
52 Week Low
$3.02

Collections

Technology
Health
Medical
Medical Devices
US
North America

News

Seeking AlphaMay 7

Activist investor nominates four board candidates at MiMedx

Institutional investor Prescience Point Capital Management, LLC, together with certain other partnerships, has nominated four "world-class" candidates to the board of directors at MiMedx (OTC:MDXG -3.3% ). The nominees are: consultant and investor M. Kathleen Behrens Wilsey, Ph.D., investor and Elcelyx Therapeutics director Richard Berry, consultant Melvin Keating and Apollo Endosurgery CEO K. Todd Newton. Prescient and the nominees own ~9.98% of the company....

10
Seeking AlphaMay 5

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q1 2019 Results - Earnings Call Transcript

Apollo Endosurgery, Inc. (NASDAQ:APEN) Q1 2019 Earnings Conference Call May 2, 2019 4:30 PM ET Company Participants John Gillings - Investors Relations Todd Newton - Chief Executive Officer Stefanie Cavanaugh - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig Hallum Andrew Stafford - Piper Jaffray Operator Good afternoon. My name is Kenzie, and I will be your conference operator today. At this time, I would like to welcome, everyone to the Apollo Endosurgery First Quarter 20...

4
Associated PressApr 30

Apollo Endosurgery, Inc. to Report First Quarter Results on May 2, 2019

Press release content from Business Wire. The AP news staff was not involved in its creation. Press release content from Business Wire. The AP news staff was not involved in its creation. AUSTIN, Texas--(BUSINESS WIRE)--Apr 30, 2019--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the first quarter ended March 31, 2019 on Thur...

8

Earnings

-$0.53
-$0.46
-$0.39
-$0.32
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.